NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 70 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,000 | 0.0% | 7,374 | +12.2% | 0.00% | – |
| Q2 2016 | $4,000 | -99.8% | 6,570 | -99.5% | 0.00% | – |
| Q1 2016 | $1,976,000 | -52.3% | 1,353,312 | +4.5% | 0.00% | -100.0% |
| Q4 2015 | $4,143,000 | -46.0% | 1,294,831 | +5.5% | 0.00% | -50.0% |
| Q3 2015 | $7,674,000 | -36.7% | 1,227,807 | +0.6% | 0.00% | -33.3% |
| Q2 2015 | $12,124,000 | +37.1% | 1,220,960 | +1.7% | 0.00% | +50.0% |
| Q1 2015 | $8,844,000 | +54.5% | 1,200,051 | +12.2% | 0.00% | +100.0% |
| Q4 2014 | $5,725,000 | +33.0% | 1,070,030 | +25.1% | 0.00% | 0.0% |
| Q3 2014 | $4,303,000 | -26.8% | 855,537 | -2.4% | 0.00% | -50.0% |
| Q2 2014 | $5,882,000 | +829.2% | 876,583 | +903.4% | 0.00% | – |
| Q1 2014 | $633,000 | +119.0% | 87,364 | +13.8% | 0.00% | – |
| Q4 2013 | $289,000 | +42.4% | 76,771 | +27.4% | 0.00% | – |
| Q3 2013 | $203,000 | +9.1% | 60,273 | +8.5% | 0.00% | – |
| Q2 2013 | $186,000 | – | 55,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |